Trade Gilead ^GILD

Best Medical Stocks To Research - June 7th - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by Capital Research Global Investors

Capital International Inc. CA Cuts Stock Holdings in Gilead Sciences, Inc. $GILD

DB&C Advisors LLC Invests $1.57 Million in Gilead Sciences, Inc. $GILD

Los Angeles Capital Management LLC Sells 676,504 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. $GILD Shares Purchased by ING Groep NV - Daily Political

Gilead Sciences (GILD), Lakefront Biotherapeutics Acquire Ouro Medicines to Advance Autoimmune Pipeline

Capital World Investors Sells 2,307,802 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Expands Into Autoimmune Orphan Diseases With Ouro Medicines Deal

SpaceX IPO Could Create 'The Biggest Short Squeeze' of All Time on Index Funds. Here's How That Happens.

Vise Technologies Inc. Purchases 11,294 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by BI Asset Management Fondsmaeglerselskab A S

111 Capital Sells 7,913 Shares of Gilead Sciences, Inc. $GILD

5 Best Quality Growth Stocks to Buy

How to use the anti-HIV jab - and where to find it

Lakefront Refocuses On T Cell Engagers With Gilead Partnership Pivot

Assembly Biosciences Eyes Gilead HSV Plan as ABI-6250 Liver Pipeline Expands - Stock Observer

Pharmaceutical Stocks To Consider - June 5th - Stock Observer

Parallel Advisors LLC Has $9.63 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax

Prudential PLC Trims Stake in Gilead Sciences, Inc. $GILD

Cibc World Market Inc. Buys 97,779 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - Daily Political

GILEAD SCIENCES EN LAKEFRONT RONDEN DE OVERNAME VAN OURO MEDICINES AF OM DE PIJPLIJN OP HET GEBIED VAN ONTSTEKINGEN VERDER UIT TE BREIDEN

GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE

TD Asset Management Inc Sells 67,251 Shares of Gilead Sciences, Inc. $GILD

Dynasty Wealth Management LLC Invests $525,000 in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences' Employee Resource Groups Run/Walk 5k To Raise Funds for Dreams for Veterans -- Dream Foundation | PRLog

Thompson Siegel & Walmsley LLC Acquires 14,995 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Data On Livdelzi And Trodelvy Points To Broader Future Mix

Natixis Advisors LLC Grows Stock Holdings in Gilead Sciences, Inc. $GILD

Marble Wealth LLC Acquires Shares of 9,588 Gilead Sciences, Inc. $GILD - Daily Political

Insider Sell: Daniel O'Day Sells 15,000 Shares of Gilead Sciences Inc (GILD)

How Investors Are Reacting To Gilead Sciences (GILD) Expanding Liver And Oncology Drug Footprint

Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 15,000 Shares

Gilead Sciences (GILD) Announces New Results From a Post Hoc Analysis

Gilead Sciences, Inc. (GILD) Gains Attention as Livdelzi Demonstrates Long-Term Efficacy and Safety

Thompson Siegel & Walmsley LLC Boosts Position in Gilead Sciences, Inc. $GILD

How Is Gilead Sciences's Stock Performance Compared to Other Healthcare Stocks

Royal Bank Of Canada Upgrades Gilead Sciences (NASDAQ:GILD) to Moderate Buy

How Liver and Oncology Wins Will Impact Gilead Sciences (GILD) Investors

Gilead (GILD) to Showcase New Cancer Therapy Data

Gilead Sciences, Inc. $GILD Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS - Zolmax

MUFG Securities EMEA plc Sells 58,888 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Privacy preserving digital platform for patient reported outcomes in inflammatory bowel disease

10 Safest Dividend Stocks to Buy Right Now

Grandfield & Dodd LLC Sells 28,306 Shares of Gilead Sciences, Inc. $GILD

Jupiter Asset Management Ltd. Increases Holdings in Gilead Sciences, Inc. $GILD - Zolmax

Koss Olinger Consulting LLC Sells 13,702 Shares of Gilead Sciences, Inc. $GILD

Savant Capital LLC Has $3.32 Million Position in Gilead Sciences, Inc. $GILD

Railway Pension Investments Ltd Sells 16,400 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Grandfield & Dodd LLC Trims Position in Gilead Sciences, Inc. $GILD - Stock Observer

Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - Daily Political

Norges Bank Takes Position in Gilead Sciences, Inc. $GILD

Eurizon Capital SGR S.p.A. Invests $117.43 Million in Gilead Sciences, Inc. $GILD

Triglav Investments D.O.O. Grows Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Valuation Check After Hepcludex Wins First FDA Approval For Hepatitis Delta

Best Pharmaceutical Stocks To Research - May 29th - Daily Political

Gilead Sciences, Inc. $GILD Shares Sold by Ilmarinen Mutual Pension Insurance Co

13,211 Shares in Gilead Sciences, Inc. $GILD Acquired by SBI Okasan Asset Management Co.Ltd. - Stock Observer

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases 424,796 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex

National Pension Service Reduces Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences Inc at Bernstein Strategic Decisions Conference Transcript

Novel Spanish, Culturally Adapted Metastatic Breast Cancer Symptom Management Guide Debuts at ASCO 2026

Harbour Investments Inc. Boosts Holdings in Gilead Sciences, Inc. $GILD

Geode Capital Management LLC Sells 232,984 Shares of Gilead Sciences, Inc. $GILD

Eukles Asset Management Cuts Position in Gilead Sciences, Inc. $GILD

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

GILD scores FDA win for HDV drug, CHMP backs Trodelvy

Todd Asset Management LLC Increases Stake in Gilead Sciences, Inc. $GILD

May 2026's Top Stocks That Could Be Trading Below Estimated Fair Value - Simply Wall St News

Gilead Sciences, Inc. $GILD Shares Sold by Simplify Asset Management Inc. - Zolmax

Simplify Asset Management Inc. Lowers Stake in Gilead Sciences, Inc. $GILD

Legal & General Group Plc Acquires 107,014 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Zacks Research Expects Lower Earnings for Gilead Sciences

Maxim Upgrades Gilead Sciences (GILD) to 'Buy'

Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference

Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Recommendation of "Moderate Buy" by Brokerages

Gilead Sciences, Inc. $GILD Shares Sold by GPS Wealth Strategies Group LLC - Zolmax

LSV Asset Management Has $508.91 Million Position in Gilead Sciences, Inc. $GILD

Global Retirement Partners LLC Grows Position in Gilead Sciences, Inc. $GILD - Stock Observer

Experimental treatments could help US Ebola patient

GILD Receives FDA Approval for Hepcludex, First Treatment for Chronic HDV Infection

Gilead Sciences Gets FDA Green Light for Chronic HDV Drug | Morningstar

US FDA approves Gilead's drug for deadly liver infection - AOL

US FDA approves Gilead's drug for deadly liver infection - Yahoo News Canada

FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)

GILD: Gilead's Trodelvy Gains Positive Opinion for TNBC Treatment in Europe

Gilead Gets Positive Opinion From European Regulators on Breast-Cancer Treatment | Morningstar

Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors

Zacks Research Forecasts Weaker Earnings for Gilead Sciences

PNC Financial Services Group Inc. Buys 53,135 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

The Week Ahead: ISM services, SMCI

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Earnings season climax

Week ahead: RBA poised to hike?

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk